Pershing Square Sohn Cancer Research Alliance Prize For Young Investigators

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print

The Pershing Square Sohn Cancer Research Alliance is taking applications for its Prize for Young Investigators in Cancer Research.

The prize of $200,000 per year for up to three years is awarded annually to at least five New York City-based scientists, enabling them to continue to pursue research at a stage when traditional funding is lacking. Each prize winner is also given a mentor in the pharmaceutical industry and the opportunity to present his or her work to scientific and business audiences.

In May 2015, PSSCRA awarded the prize to six winners: Timothy Chan, of Memorial Sloan Kettering Cancer Center; Arvin Dar, of the Icahn School of Medicine at Mount Sinai; Evripidis Gavathiotis, of Albert Einstein College of Medicine; Moritz Kircher, of MSKCC; Christine Mayr, of MSKCC; and Sohail Tavazoie, of The Rockefeller University.

In order to apply, applicants must have between two and eight years of experience running their own laboratories and must have a Ph.D., M.D., or M.D.-Ph.D. or equivalent. The deadline to submit a letter of intent is Nov. 9.

More details on the application process, including full eligibility criteria, are available on their website.

YOU MAY BE INTERESTED IN

Secretary of the U.S. Department of Health and Human Services Robert F. Kennedy Jr. appeared before the House Energy and Commerce Subcommittee on Health to defend the HHS fiscal year 2026 budget proposal, and faced criticism from several Democratic lawmakers on what they described as a lack of transparency and scientific rigor in the agency’s recent decisions.

The full-scale Russian invasion of Ukraine has devastated the Ukrainian healthcare infrastructure, disrupting cancer care, halting clinical trials, and compounding long-standing systemic challenges.  Even before the war, Ukraine’s oncology system faced major constraints: Limited access to radiotherapy equipment, outdated chemotherapy supply chains, and workforce shortages. The invasion intensified these issues—cancer hospitals were damaged, warehouses destroyed,...

Patients affected by cancer are increasingly turning to artificial intelligence-powered chatbots, such as ChatGPT and Gemini, for answers to pressing health questions. These tools, available around the clock and free from geographic or scheduling constraints, are appealing when access to medical professionals is limited by financial, language, logistical, or emotional barriers. 

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login